ECOG Performance Status

Functional status for oncology treatment decisions — 0 to 5
Performance status
Evidence
Original publication
Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Defined the ECOG performance status scale (0 fully active to 5 dead), used to stratify patients in oncology trials and to guide treatment intensity.
American Journal of Clinical Oncology, 1982
Open source
Guideline
ECOG PS 0–1 is generally required for most cytotoxic and combination regimens and for many clinical trials; PS ≥ 3 usually favours best supportive care or single-agent, lower-intensity treatment. It correlates with the Karnofsky index and is a strong independent prognostic factor.
Last reviewed: 2026-09
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.